QS Investors’s Phibro Animal Health PAHC Stock Holding History

QS Investors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-44,150	Closed	-$1.08M	–	1192
2021 Q1	$1.08M	Sell	44,150 -200	-0.5%	-$4.52K	0.01%	516
2020 Q4	$861K	Buy	44,350 +18,248	+70%	+$336K	0.01%	555
2020 Q3	$455K	Sell	26,102 -54,525	-68%	-$1.16M	0.01%	738
2020 Q2	$2.12M	Buy	80,627 +8,100	+11%	+$201K	0.03%	464
2020 Q1	$1.75M	Sell	72,527 -6,848	-9%	-$167K	0.03%	470
2019 Q4	$2.01M	Sell	79,375 -1,040	-1%	-$24.1K	0.02%	583
2019 Q3	$1.72M	Hold	80,415	–	–	0.02%	612
2019 Q2	$2.56M	Sell	80,415 -1,700	-2%	-$53.3K	0.03%	497
2019 Q1	$2.71M	Buy	82,115 +81,955	+51,222%	+$2.55M	0.03%	479
2018 Q4	$6K	Hold	160	–	–	﹤0.01%	1558
2018 Q3	$7K	Hold	160	–	–	﹤0.01%	1574
2018 Q2	$7K	Buy	160 +12	+8%	+$531	﹤0.01%	1592
2018 Q1	$6K	Buy	+148	New	+$5.48K	﹤0.01%	1604

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

QS Investors's PAHC Position: Q2 2021 in Review

QS Investors sold out of Phibro Animal Health (PAHC) in Q2 2021, closing a stake of 44,150 shares — an estimated $1.08M sold.

QS Investors first reported a position in PAHC in Q1 2018 and held it in 13 quarters. The position peaked at $2.71M in Q1 2019. 146 funds tracked by Wall St. Rank hold PAHC as of Q2 2021.

QS Investors reported no remaining Phibro Animal Health position as of Q2 2021 after selling out during the quarter.
QS Investors sold 44,150 Phibro Animal Health shares in Q2 2021, an estimated $1.08M.
QS Investors first reported a position in Phibro Animal Health in Q1 2018 and held it in 13 quarters.
QS Investors's Phibro Animal Health position peaked at $2.71M in Q1 2019.
146 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.